Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated:  5/26/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Dysmenorrhea in Women With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated: 5/26/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Oceanside, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
San Francisco, CA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Hamden, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Hamden, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Hartford, CT
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Miami, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Winter Park, FL
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Winter Park, FL
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lexington, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Louisville, KY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Baltimore, MD
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Boston, MA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Columbia, MO
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lebanon, NH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Lake Success, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
New York, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Rochester, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Troy, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Troy, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Charlotte, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Raleigh, NC
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Cincinnati, OH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Providence, RI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Providence, RI
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Nashville, TN
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Grapevine, TX
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Grapevine, TX
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Houston, TX
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Tacoma, WA
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
mi
from
Egg Harbour Township, NJ
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
mi
from
Egg Harbour Township, NJ
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Clinical Research Facility
mi
from
Great Neck, NY
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated:  7/16/2015
Research site
mi
from
San Juan,
CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring
Status: Enrolling
Updated: 7/16/2015
Research site
mi
from
San Juan,
Click here to add this to my saved trials
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Molecular Imaging to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Status: Enrolling
Updated:  7/20/2015
Brigham and Women's Hosp
mi
from
Boston, MA
PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Molecular Imaging to Predict Response to Infliximab Therapy in Patients With Crohn's Disease
Status: Enrolling
Updated: 7/20/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated:  7/28/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus DNA in Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Status: Enrolling
Updated: 7/28/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated:  7/29/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Ultrasound Stiffness Imaging in Crohn's Disease
Investigating Ultrasound Stiffness Imaging for Predicting Outcomes in Crohn's Disease
Status: Enrolling
Updated: 7/29/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated:  8/7/2015
Indiana University
mi
from
Indianapolis, IN
Can CT Enteroclysis Predict the Outcome of Crohn's Disease
Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Status: Enrolling
Updated: 8/7/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated:  8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
OPERA Database - Crohn's Protocol
IBD-OPERA Database IBD OPERA Database: Inflammatory Bowel Disease - Outcomes, Preferences, Education, Resource Utilization, Assessment Database - Crohn's Protocol
Status: Enrolling
Updated: 8/14/2015
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Status: Enrolling
Updated:  8/21/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Status: Enrolling
Updated: 8/21/2015
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Status: Enrolling
Updated:  9/16/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
A Prospective Trial of Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
Status: Enrolling
Updated: 9/16/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Immune Ablation and Stem Cell Support for Crohn's Disease
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
Status: Enrolling
Updated:  9/21/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Immune Ablation and Stem Cell Support for Crohn's Disease
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease
Status: Enrolling
Updated: 9/21/2015
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Southern California Medical Gastroenterology Group
mi
from
Santa Monica, CA
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Southern California Medical Gastroenterology Group
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Metropolitan Gastroenterology Group, Pc, Chevy Chase Cr
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated:  9/23/2015
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease
A Phase IIa, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy With BMS-936557 in Subjects With Active Crohn's Disease
Status: Enrolling
Updated: 9/23/2015
Nyu Langone Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials